Diisopropylethylamine → 4-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo-piperazin-1-ylmethyl]-piperidine-1-carboxylic acid tert-butyl ester
Reaction equation
[C:1]([O:5][C:6]([N:8]1[CH2:13][CH2:12][CH:11]([CH2:14][N:15]2[CH2:20][CH2:19][NH:18][CH2:17][C:16]2=[O:21])[CH2:10][CH2:9]1)=[O:7])([CH3:4])([CH3:3])[CH3:2].C(N(C(C)C)CC)(C)C.[Cl:31][C:32]1[CH:33]=[CH:34][C:35]2[CH:39]=[C:38]([S:40](Cl)(=[O:42])=[O:41])[S:37][C:36]=2[CH:44]=1>C(Cl)Cl.CC#N>[C:1]([O:5][C:6]([N:8]1[CH2:13][CH2:12][CH:11]([CH2:14][N:15]2[CH2:20][CH2:19][N:18]([S:40]([C:38]3[S:37][C:36]4[CH:44]=[C:32]([Cl:31])[CH:33]=[CH:34][C:35]=4[CH:39]=3)(=[O:42])=[O:41])[CH2:17][C:16]2=[O:21])[CH2:10][CH2:9]1)=[O:7])([CH3:4])([CH3:2])[CH3:3]Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 2
Procedure
To a solution of 4-(2-oxo-piperazin-1-ylmethyl)-piperidine-1-carboxylic acid tert-butyl ester (1.44 g, 4.8 mmol) in CH2Cl2 (75 mL) and MeCN (10 mL) is added diisopropylethylamine (1.3 mL, 4.8 mmol) followed by 6-chloro-benzo[b]thiophene-2-sulfonyl chloride (1.29 g, 4.8 mmol), and the reaction is allowed to stir 16 h. The reaction is diluted with CH2Cl2 and washed with 1N HCl and NaHCO3, dried and concentrated. The residue is purified by column chromatography (silica, 40% EtOAc/CH2Cl2) to provide 4-[4-(6-chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo-piperazin-1-ylmethyl]-piperidine-1-carboxylic acid tert-butyl ester. 1H NMR (300 MHz, CDCl3) δ 7.88-7.83 (m, 3H), 7.47 (dd, 1H), 4.1 (br, 2H), 3.86 (s, 2H), 3.46 (bs, 4H), 3.25 (br, 2H), 2.61 (t, 2H), 1.87-1.75 (m, 1H), 1.51 (d, 2H), 1.41 (s, 9H), 1.10 (ddd, 2H); MS (Ion spray) 528 (M+H)+.
Workup
- washwashed with 1N HCl and NaHCO3
- customdried
- concentrationconcentrated
- customThe residue is purified by column chromatography (silica, 40% EtOAc/CH2Cl2)
Sources & evidence
- ORD record
- ord-8b06f50580be4d87aa60137e6f84df57
- Source dataset
- uspto-grants-2009_11
- Patent number
- US07612075B2
Reaction notes
Loading…